2017 BioPacific Conference
Date: June 24, 2017 @ 8:30 am – @ 6:00 pm
Location: San Mateo Marriott, 1770 South Amphlett Blvd, San Mateo, CA 94402
2017 BioPacific Conference
Theme: Leading the New Wave of Life Sciences Innovation – Technology, Policy, and Investment Trends across the Pacific Rim
Our meeting will showcase:
- Winners of 2017 CABS K. Fong Award in Life Sciences
- Most promising areas in life sciences including cancer immunotherapy, genomics, and big data analytics
- Success stories of entrepreneurs and emerging companies
- Development of Innovative Therapeutics in China
- IP Considerations in Cross-border Deals between China and US Companies
- US-China Cross-Border Healthcare Investment & Entrepreneurship
- BioPartnering Forum to facilitate interactions including project introduction and talent recruitment between attendees and sponsors
Registration:
Breakfast, refreshments, lunch and evening reception are included.
CABS Member | Early Bird Registration (before 06/10/2017) | Regular Registration (06/11/2017 - 06/24/2017) |
General | $60 | $100 |
Student or Postdoc** | $50 Please use your institution email (.edu) |
$90 |
Non-Member* | Early Bird Registration (before 06/10/2017) | Regular Registration (06/11/2017-06/24/2017) |
General | $90 | $130 |
Student or Postdoc** | $80 Please use your institution email (.edu) |
$120 |
* Join CABS today ($30 for one year membership) to save $ on registration fee: http://www.cabsweb.org/members/
** Seeking for volunteers to support our conference. Free conference admission available for selected volunteers.
Email: membership@cabsweb.org
Confirmed Speakers and Panelists include:
- Thomas Hudson, MD, VP & Head of Oncology Discovery & Early Development, AbbVie
- Atul Butte, MD, PhD Director, Institute for Computational Health Sciences, UCSF
- Yinxiang Wang, PhD, Co-Founder, President and CSO, Betta Pharmaceuticals
- Edgar Engleman, MD, Managing Partner, Vivo Capital, and Professor of Pathology and of Medicine, Stanford University
- David Flores, MBA, Founder and CEO, BioCentury
- Xun Xu, MBA, President, BGI Research
- Hua Tu, PhD, CEO, Lakepharma
- Dongliang Ge, PhD, CEO, Apostle, Inc.
- Cheng Liu, PhD, CEO, Eureka Therapeutics
- Alexis Ji, PhD, MBA, Partner, Illumina Ventures
- Tarangini Deshpande, PhD, Founder & CEO, NuMedii
- Michael An, MD, PhD, Founder and CEO, Curegenix
- Wei Zheng, PhD, Founder and CEO, Suzhou Connect
- Baofu Ni, PhD, VP, Kelun Bo-Tai BioPharmaceuticals Co.
- Tao Huang, PhD, Venture Partner, Cenova Capital
- Vincent Xiang, PhD, MBA, Partner, 6 Dimensions Capital
- Karen Liu, PhD, Managing Partner, 3E Bioventures
- Julie Papanek, MBA, Partner, Canaan Partners
- Ashish Xavier, PhD, MBA, VP, Venture Investments, JNJ
- Lu Zhang, MBA, Associate Director of Business Development, Ascentage Pharma
- Johnny Sun, Co-founder and CIO, AccuraGen
- Jie Zhou, PhD, JD, Partner Morrison & Foerster
- Li Feng, PhD, JD, Partner, Finnegan
- Betty H. Chen, JD, Principal, Fish & Richardson
-
More to come
Conference Agenda:
2017 BioPacific Conference (19th Annual Conference of CABS)
Leading the New Wave of Life Sciences Innovation – Technology, Policy, and Investment Trends across the Pacific Rim
8:00 AM – 8:30 AM |
REGISTRATION |
Morning Session I: Welcome & Keynote Speeches
Session Chair: Yang Tian, PhD, and Carrie Wang, MD
8:30 AM – 8:35 AM |
Welcome Remarks Alex J. Zhang, PhD, MBA, President-Elect of CABS & 2017 BioPacific Conference Organizing Committee Chair |
8:35 AM – 8:45 AM |
A Year of Many Firsts at CABS Cheni Kwok, PhD CLP, President of CABS |
8:45 AM – 9:20 AM |
Immuno-oncology: What’s next? Thomas Hudson, MD, VP, Head of Oncology Discovery and Early Development, AbbVie |
9:20 AM – 9:55 AM |
Translating a Trillion Points of Data into Therapies, Diagnostics, and New Insights into Disease Atul Butte, MD, PhD, Director, Institute for Computational Health Sciences and UCSF Distinguished Professor of Pediatrics, University of California, San Francisco |
9:55 AM-10:10 AM |
BREAK |
Morning Session II: 2017 CABS K. Fong Award
Session Chair: Wentao Zhang, PhD
10:10 AM-10:20 AM |
CABS K. Fong Award in Life Sciences Presenter: Kenneth Fong, PhD, Chairman, Kenson Ventures |
10:20 AM – 10:35 AM |
Award Acceptance Speech (via Video) Yinxiang Wang, PhD, Co-Founder, President, and CSO, Beta Pharmaceuticals |
10:35 AM – 11:05 AM |
Immunotherapy for Cancer: A Paradigm Shift Edgar Engleman, MD, Managing Partner, Vivo Capital, and Professor of Pathology and of Medicine, Stanford University |
Morning Session III: Panel Discussion
Session Chair: Yan Wang, PhD, and Gavin Lu, PhD
11:05 AM – 11:20 AM |
Diamond Sponsor: Chengdu Medical City Zhao Yang, President of Chengdu Geunion Investment Co., Ltd |
11:20 AM – 11:55 AM |
IP Considerations in Cross-border Deals between China and US Companies Moderator, Gini Deshpande, PhD, CEO, NuMedii Panelist, Jie Zhou, PhD, JD, Partner, Morrison & Foerster, LLP Panelist, Li Feng, PhD, JD, Partner, Finnegan Panelist, Betty Chen, JD, Principal, Fish & Richardson |
11:55 AM – 12:15 PM |
Platinum Sponsor: Singapore-Sichuan Hi-Tech Innovation Park Wilson Lee, Director, Sino-Singapore (Chengdu) Innovation Park Development Co., Ltd. Platinum Sponsor#2: Kelun Pharmaceuticals Group Co., Ltd. Baofu (Paul ) Ni, PhD, VP, Kelun Bo-Tai Biopharmacetical Co. Ltd., and Senior Director of Kelun Pharmaceutical Research Institute |
12:15 PM – 1:00 PM |
LUNCH BREAK |
Afternoon Session I: Keynote Speeches
Session Chair: Wenfeng Xu, PhD, Ziyang Zhong, PhD, and Naibo Yang, PhD
1:00 PM – 1:30 PM |
First Principles of Global Leadership David Flores, MBA, Founder and CEO, BioCentury |
1:30 PM – 2:00 PM |
Genome Reading and Writing in CNGB Xun Xu, MBA, President, BGI Research Institute |
2:00 PM – 2:30 PM |
Meeting the market needs and creating sustaining value – the LakePharma story Hua Tu, PhD, Founder & CEO, LakePharma |
2:30 PM – 2:45 PM |
Sponsor Session: Gold sponsors
|
Afternoon Panel Session I: Developing Innovative Therapeutics in China
Session Chair: Xiaoli Qin, PhD, and Wei Huang
2:45 PM –3:30PM |
Moderator, Cheng Liu, PhD, CEO, Eureka Therapeutics Panelist, Michael An, PhD, Founder and CEO, Curegenix Panelist, Wei Zheng, PhD, Founder and CEO, Suzhou Connect Panelist, Baofu (Paul ) Ni, PhD, P, Kelun Bo-Tai Biopharmacetical Co. Ltd., and Senior Director of Kelun Pharmaceutical Research Institute Panelist, Tao Huang, PhD, JD, Venture Partner, Cenova Capital |
3:30 PM – 3:55 PM |
COFFEE BREAK |
Afternoon Session II: Investment and Entrepreneurship
Session Chair: Dannis Chang, PharmD, and Shenshen Hu, PhD
3:55 PM – 4:05 PM |
Sponsor Session: Gold sponsors
|
4:05 PM – 4:35PM |
Genomic Medicine and Modern Biotechnology Revolution: My Three Stories Dongliang Ge, PhD, CEO, Apostle, Inc. |
4:35 PM – 5:30 PM |
Afternoon Panel Discussion II: E-Club: Entrepreneurship and Investment Trends in Life Sciences Moderator, Alexis Ji, PhD, MBA, Illumina Ventures Panelist, Vincent Xiang, PhD, MBA, Partner, 6 Dimensions Capital Panelist, Karen Liu, PhD, Managing Partner, 3E Bioventures Panelist, Julie Papanek, MBA, Partner, Canaan Partners Panelist, Asish Xavier, PhD, MBA, VP, Venture Investments, JNJ Panelist, Lu Zhang, MBA, Associate Director of Business Development, Ascentage Pharma Panelist, Johnny Sun, MS, Co-founder and CIO, AccuraGen |
5:30 PM |
CONFERENCE ADJOURNED |
5:30 PM – 8:30 PM |
Post-Conference Reception Sponsored by Chengdu Medical City (Engage Room and Courtyard) Session Chair: Sihong Zhou and Ken Zhang, PhD |
CABS would like to express our sincere gratitude to all our sponsors for supporting us:
Limited Sponsorship Opportunities Still Available !
Email: fundraising@cabsweb.org
Questions? Email: info@cabsweb.org
Please use your own edu email address to register
Please use your own edu email address to register
Complimentary registration for speakers, panelists and their guests.
You will need to have a special promotion code to get free registration
.